Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinder Morgan
KMI
|
+$304M |
| 2 |
Microsoft
MSFT
|
+$131M |
| 3 |
Meta Platforms (Facebook)
META
|
+$127M |
| 4 |
Apple
AAPL
|
+$106M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$35.5M |
| 2 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$31M |
| 3 |
TWTC
TW TELECOM INC CL A COM
TWTC
|
+$30.1M |
| 4 |
Automatic Data Processing
ADP
|
+$25.7M |
| 5 |
URS
URS CORP
URS
|
+$20.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.59% |
| 2 | Technology | 14.55% |
| 3 | Healthcare | 14.21% |
| 4 | Industrials | 10.66% |
| 5 | Consumer Discretionary | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Novartis
NVS
$297B
| $2.44M | ﹤0.01% |
29,337
+320
| +1% | +$26.5K |
|
2277
Patrick Industries
PATK
$2.74B
| $2.43M | ﹤0.01% |
186,800
+1,401
| +0.8% | +$17.7K |
|
2278
Ryanair
RYAAY
$30.4B
| $2.43M | ﹤0.01% |
83,170
+12,085
| +17% | +$302K |
|
|
REV
2279
DELISTED
Revlon, Inc.
REV
| $2.43M | ﹤0.01% |
71,073
+2,428
| +4% | +$80.7K |
|
2280
DHI Group
DHX
$182M
| $2.43M | ﹤0.01% |
242,366
+1,440
| +0.6% | +$14.2K |
|
|
GNCMA
2281
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $2.42M | ﹤0.01% |
176,328
+294
| +0.2% | +$3.52K |
|
|
IL
2282
DELISTED
IntraLinks Holdings Inc.
IL
| $2.42M | ﹤0.01% |
203,451
+6,479
| +3% | +$62.9K |
|
|
ADVM
2283
DELISTED
Adverum Biotechnologies
ADVM
| $2.42M | ﹤0.01% |
4,475
+1,078
| +32% | +$416K |
|
2284
Medifast
MED
$109M
| $2.41M | ﹤0.01% |
71,777
+2,877
| +4% | +$89.6K |
|
|
MYCC
2285
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $2.41M | ﹤0.01% |
134,293
+801
| +0.6% | +$15.1K |
|
|
HVB
2286
DELISTED
HUDSON VY HLDG CORP
HVB
| $2.4M | ﹤0.01% |
88,233
+4,376
| +5% | +$104K |
|
|
HTO
2287
H2O America
HTO
$2.57B
| $2.39M | ﹤0.01% |
74,491
+4,478
| +6% | +$135K |
|
|
SHOE
2288
Shoe Station Group
SHOE
$413M
| $2.39M | ﹤0.01% |
185,964
+6,488
| +4% | +$66.7K |
|
|
AERI
2289
DELISTED
Aerie Pharmaceuticals
AERI
| $2.39M | ﹤0.01% |
81,810
+5,738
| +8% | +$146K |
|
|
BV
2290
DELISTED
Bazaarvoice, Inc.
BV
| $2.38M | ﹤0.01% |
296,251
+6,250
| +2% | +$46.5K |
|
|
IPHI
2291
DELISTED
INPHI CORPORATION
IPHI
| $2.38M | ﹤0.01% |
128,626
+1,106
| +0.9% | +$16.2K |
|
|
MESG
2292
DELISTED
XURA INC COM (DE)
MESG
| $2.38M | ﹤0.01% |
126,571
-728
| -0.6% | -$14.7K |
|
|
MWW
2293
DELISTED
Monster Worldwide Inc
MWW
| $2.37M | ﹤0.01% |
513,474
+2,894
| +0.6% | +$12.7K |
|
|
SP
2294
DELISTED
SP Plus Corporation
SP
| $2.37M | ﹤0.01% |
93,913
+3,051
| +3% | +$66.2K |
|
2295
Option Care Health
OPCH
$3.45B
| $2.36M | ﹤0.01% |
84,329
+967
| +1% | +$24K |
|
|
RT
2296
DELISTED
Ruby Tuesday Georgia
RT
| $2.35M | ﹤0.01% |
344,387
+2,107
| +0.6% | +$15.7K |
|
2297
John B. Sanfilippo & Son
JBSS
$967M
| $2.35M | ﹤0.01% |
51,717
+13,277
| +35% | +$520K |
|
|
SFE
2298
DELISTED
Safeguard Scientifics, Inc.
SFE
| $2.35M | ﹤0.01% |
118,684
| – | – |
|
|
RDUS
2299
DELISTED
Radius Health, Inc.
RDUS
| $2.35M | ﹤0.01% |
60,432
+25,754
| +74% | +$611K |
|
|
GFIG
2300
DELISTED
GFI GROUP INC
GFIG
| $2.35M | ﹤0.01% |
431,002
+21,011
| +5% | +$110K |
|
Similar funds
Geode Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Geode Capital Management held 4,051 positions worth $168B, up 9% from $154B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management deployed $5.23B of net new capital in Q4 2014, opening 130 new positions and adding to 2,924 existing holdings. Its largest new stake was CDK Global, Inc.: 836,934 shares worth $34.1M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Agilent Technologies, an estimated $35.5M trimmed.
- Geode Capital Management's largest Q4 2014 buy was CDK Global, Inc.: 836,934 shares worth $34.1M.
- Geode Capital Management added most to Kinder Morgan in Q4 2014, an estimated $304M increase.
- Geode Capital Management's biggest Q4 2014 reduction was Agilent Technologies, cutting an estimated $35.5M.
- Geode Capital Management fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $31M.
- Geode Capital Management's ten largest holdings make up 15% of its $168B portfolio in Q4 2014.
- Geode Capital Management opened 130 new positions and closed 76 in Q4 2014.
- Geode Capital Management's portfolio value rose 9% quarter-over-quarter to $168B.
Based on Geode Capital Management's 13F filing for Q4 2014, filed 12 Feb 2015.